These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34443334)

  • 21. New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis.
    Sainz Y; Montoya ME; Martínez-Crespo FJ; Ortega MA; López de Ceráin A; Monge A
    Arzneimittelforschung; 1999 Jan; 49(1):55-9. PubMed ID: 10028381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-2-[3-(3,4-dichlorophenyl)-1-oxo-2-propenyl]-3-methylquinoxaline-1,4-dioxide: a lead antitubercular agent which alters mitochondrial respiration in rat liver.
    Das U; Das S; Bandy B; Gorecki DK; Dimmock JR
    Eur J Med Chem; 2010 Oct; 45(10):4682-6. PubMed ID: 20705367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents.
    Torres E; Moreno E; Ancizu S; Barea C; Galiano S; Aldana I; Monge A; Pérez-Silanes S
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3699-703. PubMed ID: 21570839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review on various heterocyclic moieties and their antitubercular activity.
    Sharma S; Sharma PK; Kumar N; Dudhe R
    Biomed Pharmacother; 2011 Jul; 65(4):244-51. PubMed ID: 21715130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
    Jaso A; Zarranz B; Aldana I; Monge A
    J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.
    Jaso A; Zarranz B; Aldana I; Monge A
    Eur J Med Chem; 2003 Sep; 38(9):791-800. PubMed ID: 14561478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.
    Ancizu S; Moreno E; Torres E; Burguete A; Pérez-Silanes S; Benítez D; Villar R; Solano B; Marín A; Aldana I; Cerecetto H; González M; Monge A
    Molecules; 2009 Jun; 14(6):2256-72. PubMed ID: 19553897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinoxaline 1,4-di-N-oxide and the potential for treating tuberculosis.
    Vicente E; Villar R; Pérez-Silanes S; Aldana I; Goldman RC; Mong A
    Infect Disord Drug Targets; 2011 Apr; 11(2):196-204. PubMed ID: 21470099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.
    Vicente E; Pérez-Silanes S; Lima LM; Ancizu S; Burguete A; Solano B; Villar R; Aldana I; Monge A
    Bioorg Med Chem; 2009 Jan; 17(1):385-9. PubMed ID: 19058970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2D QSAR Analysis of Substituted Quinoxalines for their Antitubercular and Antileptospiral Activities.
    Natarajan R; Puratchikody A; Muralidharan V; Doble M; Subramani A
    Curr Comput Aided Drug Des; 2019; 15(2):182-192. PubMed ID: 30317999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent progress on pyrazole scaffold-based antimycobacterial agents.
    Keri RS; Chand K; Ramakrishnappa T; Nagaraja BM
    Arch Pharm (Weinheim); 2015 May; 348(5):299-314. PubMed ID: 25820461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and preliminary in vitro evaluation of antimycobacterial activity of new pyrrolo[1,2-a] quinoxaline-carboxylic acid hydrazide derivatives.
    Guillon J; Reynolds RC; Leger JM; Guie MA; Massip S; Dallemagne P; Jarry C
    J Enzyme Inhib Med Chem; 2004 Dec; 19(6):489-95. PubMed ID: 15662953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triazole derivatives and their anti-tubercular activity.
    Zhang S; Xu Z; Gao C; Ren QC; Chang L; Lv ZS; Feng LS
    Eur J Med Chem; 2017 Sep; 138():501-513. PubMed ID: 28692915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Comprehensive Examination of Heterocyclic Scaffold Chemistry for Antitubercular Activity.
    Bendi A; Yadav P; Saini K; Singh Bhathiwal A; Raghav N
    Chem Biodivers; 2024 May; 21(5):e202400067. PubMed ID: 38500408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.
    Seitz LE; Suling WJ; Reynolds RC
    J Med Chem; 2002 Dec; 45(25):5604-6. PubMed ID: 12459027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinoxaline derivatives as potential antituberculotic agents.
    Kunes J; Spulák M; Waisser K; Slosárek M; Janota J
    Pharmazie; 2000 Nov; 55(11):858-9. PubMed ID: 11126007
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-tubercular activity of novel class of spiropyrrolidine tethered indenoquinoxaline heterocyclic hybrids.
    Arumugam N; Almansour AI; Suresh Kumar R; Ibrahim Alaqeel S; Siva Krishna V; Sriram D
    Bioorg Chem; 2020 Jun; 99():103799. PubMed ID: 32247109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
    Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
    Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.
    Ortega MA; Sainz Y; Montoya ME; López De Ceráin A; Monge A
    Pharmazie; 1999 Jan; 54(1):24-5. PubMed ID: 9987794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
    Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
    Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.